Hyperinsulinemia associated with overweight medicated bipolar patients during full remission

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Aims: Insulin resistance, quantified by hyperinsulinemia, has been identified as a preclinical state for metabolic syndrome. Acute medicated bipolar patients are vulnerable to hyperinsulinemia in early remission. We examined the proportion of fasting serum insulin levels in remitted bipolar patients and considered what factors may contribute to hyperinsulinemia. Methods: Measurements taken in this study included the fasting plasma levels of insulin, glucose, triglycerides, total cholesterol, high-density-lipoprotein- cholesterol, low-density-lipoprotein-cholesterol, and the body mass index (BMI) among 56 bipolar I manic patients in full remission. We examined serum insulin levels in order to explore the correlation between and within the hyperinsulinemia and non-hyperinsulinemia groups. Results: A total of 15 patients (26.8%) were identified as having hyperinsulinemia. Among all factors, only BMI was associated with higher serum insulin level (BMI ≤yen; 24: odds ratio of 8.57; P <0.01; 95% confidence interval, 1.65-44.43). Conclusion: Hyperinsulinemia was not more prevalent in medicated euthymic bipolar patients compared with the general population. However, increasing bodyweight may make these patients more vulnerable to hyperinsulinemia, irrespective of their mood stabilizers or antipsychotics. Weight management should not be ignored in euthymic bipolar patients to prevent the preclinical state for metabolic syndrome.

Original languageEnglish
Pages (from-to)620-624
Number of pages5
JournalPsychiatry and Clinical Neurosciences
Volume64
Issue number6
DOIs
Publication statusPublished - Dec 2010

Fingerprint

Hyperinsulinism
Insulin
Body Mass Index
Fasting
Serum
LDL Cholesterol
HDL Cholesterol
Antipsychotic Agents
Insulin Resistance
Triglycerides
Odds Ratio
Cholesterol
Confidence Intervals
Weights and Measures
Glucose
Population

Keywords

  • bipolar disorder
  • euthymic bipolar patients
  • hyperinsulinemia
  • overweight

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Psychiatry and Mental health
  • Neuroscience(all)

Cite this

@article{891cfd62e0f04c859223d1c631fa34b0,
title = "Hyperinsulinemia associated with overweight medicated bipolar patients during full remission",
abstract = "Aims: Insulin resistance, quantified by hyperinsulinemia, has been identified as a preclinical state for metabolic syndrome. Acute medicated bipolar patients are vulnerable to hyperinsulinemia in early remission. We examined the proportion of fasting serum insulin levels in remitted bipolar patients and considered what factors may contribute to hyperinsulinemia. Methods: Measurements taken in this study included the fasting plasma levels of insulin, glucose, triglycerides, total cholesterol, high-density-lipoprotein- cholesterol, low-density-lipoprotein-cholesterol, and the body mass index (BMI) among 56 bipolar I manic patients in full remission. We examined serum insulin levels in order to explore the correlation between and within the hyperinsulinemia and non-hyperinsulinemia groups. Results: A total of 15 patients (26.8{\%}) were identified as having hyperinsulinemia. Among all factors, only BMI was associated with higher serum insulin level (BMI ≤yen; 24: odds ratio of 8.57; P <0.01; 95{\%} confidence interval, 1.65-44.43). Conclusion: Hyperinsulinemia was not more prevalent in medicated euthymic bipolar patients compared with the general population. However, increasing bodyweight may make these patients more vulnerable to hyperinsulinemia, irrespective of their mood stabilizers or antipsychotics. Weight management should not be ignored in euthymic bipolar patients to prevent the preclinical state for metabolic syndrome.",
keywords = "bipolar disorder, euthymic bipolar patients, hyperinsulinemia, overweight",
author = "Chung, {Kuo Hsuan} and Tsai, {Shang Ying}",
year = "2010",
month = "12",
doi = "10.1111/j.1440-1819.2010.02137.x",
language = "English",
volume = "64",
pages = "620--624",
journal = "Psychiatry and Clinical Neurosciences",
issn = "1323-1316",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Hyperinsulinemia associated with overweight medicated bipolar patients during full remission

AU - Chung, Kuo Hsuan

AU - Tsai, Shang Ying

PY - 2010/12

Y1 - 2010/12

N2 - Aims: Insulin resistance, quantified by hyperinsulinemia, has been identified as a preclinical state for metabolic syndrome. Acute medicated bipolar patients are vulnerable to hyperinsulinemia in early remission. We examined the proportion of fasting serum insulin levels in remitted bipolar patients and considered what factors may contribute to hyperinsulinemia. Methods: Measurements taken in this study included the fasting plasma levels of insulin, glucose, triglycerides, total cholesterol, high-density-lipoprotein- cholesterol, low-density-lipoprotein-cholesterol, and the body mass index (BMI) among 56 bipolar I manic patients in full remission. We examined serum insulin levels in order to explore the correlation between and within the hyperinsulinemia and non-hyperinsulinemia groups. Results: A total of 15 patients (26.8%) were identified as having hyperinsulinemia. Among all factors, only BMI was associated with higher serum insulin level (BMI ≤yen; 24: odds ratio of 8.57; P <0.01; 95% confidence interval, 1.65-44.43). Conclusion: Hyperinsulinemia was not more prevalent in medicated euthymic bipolar patients compared with the general population. However, increasing bodyweight may make these patients more vulnerable to hyperinsulinemia, irrespective of their mood stabilizers or antipsychotics. Weight management should not be ignored in euthymic bipolar patients to prevent the preclinical state for metabolic syndrome.

AB - Aims: Insulin resistance, quantified by hyperinsulinemia, has been identified as a preclinical state for metabolic syndrome. Acute medicated bipolar patients are vulnerable to hyperinsulinemia in early remission. We examined the proportion of fasting serum insulin levels in remitted bipolar patients and considered what factors may contribute to hyperinsulinemia. Methods: Measurements taken in this study included the fasting plasma levels of insulin, glucose, triglycerides, total cholesterol, high-density-lipoprotein- cholesterol, low-density-lipoprotein-cholesterol, and the body mass index (BMI) among 56 bipolar I manic patients in full remission. We examined serum insulin levels in order to explore the correlation between and within the hyperinsulinemia and non-hyperinsulinemia groups. Results: A total of 15 patients (26.8%) were identified as having hyperinsulinemia. Among all factors, only BMI was associated with higher serum insulin level (BMI ≤yen; 24: odds ratio of 8.57; P <0.01; 95% confidence interval, 1.65-44.43). Conclusion: Hyperinsulinemia was not more prevalent in medicated euthymic bipolar patients compared with the general population. However, increasing bodyweight may make these patients more vulnerable to hyperinsulinemia, irrespective of their mood stabilizers or antipsychotics. Weight management should not be ignored in euthymic bipolar patients to prevent the preclinical state for metabolic syndrome.

KW - bipolar disorder

KW - euthymic bipolar patients

KW - hyperinsulinemia

KW - overweight

UR - http://www.scopus.com/inward/record.url?scp=78649652531&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649652531&partnerID=8YFLogxK

U2 - 10.1111/j.1440-1819.2010.02137.x

DO - 10.1111/j.1440-1819.2010.02137.x

M3 - Article

C2 - 21040189

AN - SCOPUS:78649652531

VL - 64

SP - 620

EP - 624

JO - Psychiatry and Clinical Neurosciences

JF - Psychiatry and Clinical Neurosciences

SN - 1323-1316

IS - 6

ER -